Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial von Butts, Charles, Dr, Socinski, Mark A, Prof, Mitchell, Paul L, MD, Thatcher, Nick, Prof, Havel, Libor, MD, Krzakowski, Maciej, Prof, Nawrocki, Sergiusz, MD, Ciuleanu, Tudor-Eliade, MD, Bosquée, Lionel, MD, Trigo, José Manuel, MD, Spira, Alexander, MD, Tremblay, Lise, MD, Nyman, Jan, MD, Ramlau, Rodryg, MD, Wickart-Johansson, Gun, MD, Ellis, Peter, MD, Gladkov, Oleg, MD, Pereira, José Rodrigues, MD, Eberhardt, Wilfried Ernst Erich, MD, Helwig, Christoph, Dipl Stat, Schröder, Andreas, MD, Shepherd, Frances A, Prof

Volltext

Scattering by small thin dielectric particles von Ksienski, D. A., Senior, T. B. A.

Volltext

A method of resolving data into two maximmaly smooth components von KSIENSKI, D. A

Volltext

A method of resolving data into two maximally smooth components von Ksienski, D.A.

Volltext

Numerical Methods of Noise Reduction for Frequency Domain SEM von Ksienski, David A., Willis, Thomas M.

Volltext

Earth-coverage beams from geosynchronous active transmit phased arrays von Ksienski, D.A.

Volltext bestellen

A Numerical Analysis Of The Electric Field Generated By A Nerve Cuff Electrode von Chintalacharuvu, R.R., Ksienski, D.A., Mortimer, J.T.

Volltext bestellen

A nerve cuff technique for selective motor control von Sweeney, J.D., Ksienski, D.A., Mortimer, J.T.

Volltext bestellen

A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213 von Bernstein, V., Ellard, S. L., Dent, S. F., Tu, D., Mates, M., Dhesy-Thind, S. K., Panasci, L., Gelmon, K. A., Salim, M., Song, X., Clemons, M., Ksienski, D., Verma, S., Simmons, C., Lui, H., Chi, K., Feilotter, H., Hagerman, L. J., Seymour, L.

Volltext

Mandatory Health Care Worker Influenza Vaccination or Masking in British Columbia von Ksienski, D

Volltext

Treatment of non-small-cell lung cancer after progression on nivolumab or pembrolizumab von Freeman, A T, Lesperance, M, Wai, E S, Croteau, N S, Fiorino, L, Geller, G, Brooks, E G, Poonja, Z, Fenton, D, Irons, S, Ksienski, D

Volltext

Survival Outcomes Following Discontinuation of Ipilimumab and Nivolumab for Advanced Melanoma in a Population-based Cohort von Ksienski, D., Truong, P.T., Wai, E.S., Croteau, N.S., Chan, A., Patterson, T., Clarkson, M., Hackett, S., Irons, S., Lesperance, M.

Volltext

Real World Immunotherapy Response and Pulmonary Toxicity in Patients Treated with Chest Radiation Therapy von Glick, D., Wai, E.S., Brooks, E., Fenton, D., Fiorino, L., Geller, G., Poonja, Z., Ksienski, D.

Volltext

Factors associated with decision making for use of adjuvant chemotherapy (AT) in referred patients (pts) with resected high-risk colon cancer (CC) von Ksienski, D., Gill, S.

Volltext

P1.01-50 Real World Experience of Nivolumab in Patients with Metastatic Nonsmall Cell Lung Cancer (mNSCLC) von Ksienski, D., Wai, E., Lesperance, M., Croteau, N., Fiorino, L., Poonja, Z., Geller, G., Fenton, D., Brooks, E., Glick, D.

Volltext

P1.01-51 Real world Experience of Pembrolizumab in Patients with Metastatic Nonsmall Cell Lung Cancer (mNSCLC) von Ksienski, D., Wai, E., Lesperance, M., Croteau, N., Fiorino, L., Poonja, Z., Fenton, D., Geller, G., Brooks, E., Glick, D.

Volltext

P1.01-24 Clinical Efficacy of Immunotherapy in Metastatic Non-Small Cell Lung Cancer Patients Treated with Prior Radiotherapy von Glick, D., Wai, E., Lesperance, M., Croteau, N., Brooks, E., Fenton, D., Fiorino, L., Geller, G., Poonja, Z., Ksienski, D.

Volltext

MA07.11 Survival Outcomes Based on Gender of Advanced Nonsmall Cell Lung Cancer Patients Treated with Pembrolizumab or Nivolumab in Everyday Clinical Practice von Ksienski, D., Wai, E., Croteau, N., Freeman, A., Fiorino, L., Chan, A., Fenton, D., Geller, G., Brooks, E., Poonja, Z., Irons, S., Lesperance, M.

Volltext

Predictors of adjuvant chemotherapy (AT) decision-making in referred patients (pts) with stage II and III colon cancer (CC) von Ksienski, D. S., Levesque, M., Gill, S.

Volltext

Cost-minimization analysis (CMA) of capecitabine plus oxaliplatin (XELOX) compared with modified FOLFOX6 (mFOLFOX6) for the adjuvant treatment of resected colon cancer in British C... von Yunger, S., Mistry, B., Cheung, W. Y., Ksienski, D., Urspruch, A.

Volltext